Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma

非髓样甲状腺癌患者髓系细胞及其祖细胞的重编程

阅读:3
作者:Katrin Rabold # ,Martijn Zoodsma # ,Inge Grondman ,Yunus Kuijpers ,Manita Bremmers ,Martin Jaeger ,Bowen Zhang ,Willemijn Hobo ,Han J Bonenkamp ,Johannes H W de Wilt ,Marcel J R Janssen ,Lenneke A M Cornelissen ,Ilse C H van Engen-van Grunsven ,Willem J M Mulder ,Jan W A Smit ,Gosse J Adema ,Mihai G Netea ,Yang Li ,Cheng-Jian Xu ,Romana T Netea-Maier

Abstract

Myeloid cells, crucial players in antitumoral defense, are affected by tumor-derived factors and treatment. The role of myeloid cells and their progenitors prior to tumor infiltration is poorly understood. Here we show single-cell transcriptomics and functional analyses of the myeloid cell lineage in patients with non-medullary thyroid carcinoma (TC) and multinodular goiter, before and after treatment with radioactive iodine compared to healthy controls. Integrative data analysis indicates that monocytes of TC patients have transcriptional upregulation of antigen presentation, reduced cytokine production capacity, and overproduction of reactive oxygen species. Interestingly, these cancer-related pathological changes are partially removed upon treatment. In bone marrow, TC patients tend to shift from myelopoiesis towards lymphopoiesis, reflected in transcriptional differences. Taken together, distinct transcriptional and functional changes in myeloid cells arise before their infiltration of the tumor and are already initiated in bone marrow, which suggests an active role in forming the tumor immune microenvironment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。